This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Burdett, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Burdett, V.

 Previous Article  |  Next Article 

J. Bacteriol., 06 1996, 3246-3251, Vol 178, No. 11
Copyright © 1996, American Society for Microbiology

Tet(M)-promoted release of tetracycline from ribosomes is GTP dependent

V Burdett
Department of Microbiology, Duke University Medical Center, Durham, North Carolina 27710, USA.

Tet(M) protein, which displays homology to elongation factor G (EF-G), interacts with the protein biosynthetic machinery to render this process resistant to tetracycline in vivo and in vitro. To clarify the basis of the resistance mechanism, the effects of Tet(M) on several reactions which occur during protein synthesis were examined. The mechanism of action of Tet(M) has been clarified by two observations. The protein relieves tetracycline inhibition of factor-dependent tRNA binding and dramatically reduces the affinity of ribosomes for tetracycline when GTP is present. This reduction in drug affinity appears to be due to a large increase in the rate of tetracycline dissociation. Addition of Tet(M) to ribosome-tetracycline complexes results in displacement of bound drug. And, while Tet(M) and EF-G GTPase activities are tetracycline resistant, the two proteins differ in their sensitivities to fusidic acid, with the latter activity inhibited by the drug. Furthermore, while Tet(M) protects translation from tetracycline inhibition in a defined system, it is unable to substitute for either EF-G or elongation factor Tu.


This article has been cited by other articles:

  • Connell, S. R., Tracz, D. M., Nierhaus, K. H., Taylor, D. E. (2003). Ribosomal Protection Proteins and Their Mechanism of Tetracycline Resistance. Antimicrob. Agents Chemother. 47: 3675-3681 [Full Text]  
  • Lazaro, E., Sanz, E., Remacha, M., Ballesta, J. P. G. (2002). Characterization of Sparsomycin Resistance in Streptomyces sparsogenes. Antimicrob. Agents Chemother. 46: 2914-2919 [Abstract] [Full Text]  
  • Chopra, I., Roberts, M. (2001). Tetracycline Antibiotics: Mode of Action, Applications, Molecular Biology, and Epidemiology of Bacterial Resistance. Microbiol. Mol. Biol. Rev. 65: 232-260 [Abstract] [Full Text]  
  • Eady, E. A., Coates, P., Ross, J. I., Ratyal, A. H., Cove, J. H. (2000). Antibiotic resistance patterns of aerobic coryneforms and furazolidone-resistant Gram-positive cocci from the skin surface of the human axilla and fourth toe cleft. J Antimicrob Chemother 46: 205-213 [Abstract] [Full Text]  
  • Nelson, M. L., Levy, S. B. (1999). Reversal of Tetracycline Resistance Mediated by Different Bacterial Tetracycline Resistance Determinants by an Inhibitor of the Tet(B) Antiport Protein. Antimicrob. Agents Chemother. 43: 1719-1724 [Abstract] [Full Text]  
  • Dantley, K. A., Dannelly, H. K., Burdett, V. (1998). Binding Interaction between Tet(M) and the Ribosome: Requirements for Binding. J. Bacteriol. 180: 4089-4092 [Abstract] [Full Text]  
  • Ross, J. I., Eady, E. A., Cove, J. H., Cunliffe, W. J. (1998). 16S rRNA Mutation Associated with Tetracycline Resistance in a Gram-Positive Bacterium. Antimicrob. Agents Chemother. 42: 1702-1705 [Abstract] [Full Text]  
  • Taylor, D. E., Trieber, C. A., Trescher, G., Bekkering, M. (1998). Host Mutations (miaA and rpsL) Reduce Tetracycline Resistance Mediated by Tet(O) and Tet(M). Antimicrob. Agents Chemother. 42: 59-64 [Abstract] [Full Text]